Immunohistochemistry showed that olaparib and ONC206 significantly reduced expression of Ki-67, a marker of tumor cell proliferation, in both obese and lean mice, with more potent effects with combination treatment (Figure 4C). The gene discussed is MKI67; the disease is neoplasm.